Wikidata

(Q34528550)

English

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12409327
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12409327%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34528550&oldid=2143832071"